Results
eNauka >
Results >
Original Research Preference for the fixed-dose combination of pertuzumab and trastuzumab for subcutaneous injection in patients with HER2-positive early breast cancer (PHranceSCa): A randomised, open-label phase II study
| Title: | Original Research Preference for the fixed-dose combination of pertuzumab and trastuzumab for subcutaneous injection in patients with HER2-positive early breast cancer (PHranceSCa): A randomised, open-label phase II study | Authors  : | O'Shaughnessy, Joyce; ...; Cvetanovic, Ana S; ...; Stamatovic, Ljiljana | Issue Date: | 2021 | Publication: | EUROPEAN JOURNAL OF CANCER | ISSN: | 0959-8049 European Journal of Cancer / EJC Search Idenfier |
Type: | Article | Collation: | vol. 152 str. 223-232 | DOI: | 10.1016/j.ejca.2021.03.047 | WoS-ID: | 000678059500021 | Scopus-ID: | 2-s2.0-85107914072 | URI: | https://zenodo.org/record/5196150 https://enauka.gov.rs/handle/123456789/935206 |
Project: | F. Hoffmann-La Roche Ltd.Hoffmann-La Roche | Metadata source: | (Preuzeto iz Nasi u WoS) | M-category: | 21aM21a |
Items in eNauka are protected by copyright, with all rights reserved, unless otherwise indicated.